ASRT: Total Utang marang Modal Assertio Therapeutics
Assertio Holdings, Inc. (ASRT) is currently reviewing its neurological drug portfolio and restructuring internal processes following the consolidation of assets to return to profitability. Large loans and competition from affordable generics are undermining the company's financial stability. The market capitalization trend based on the total debt-to-equity ratio is fixed at 0.51, while the company is implementing wastewater treatment systems and the safe disposal of chemical waste.
%20-%20Utang%20marang%20Modal&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_ASRT_-_Assertio-Holdings-Inc._-_Debt-to-Capital "Rasio Total Utang marang Ekuitas: Assertio (ASRT) kanggo 04.07.2022 - 27.06.2026 | 👁️GURU.Markets👁️")
Rincian metrik lan analitis perusahaan Assertio (ASRT)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Assertio Holdings, Inc.|ASRT - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Assertio Holdings|ASRT - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Assertio|ASRT - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Assertio|Rasio cepet assertiotx.com
- statistik bathi lan rasio pasar:
Analisis dhasar perusahaan:ASRT, Assertio Holdings, Inc.
Assertio Holdings, Inc. (ASRT) is minimizing its reliance on individual patents and stabilizing cash flows through the diversification of its neurological drug portfolio and the development of digital sales channels. By analyzing the total liabilities-to-equity ratio, investors assess the balance between debt and equity, where an increase in this metric signals rising credit risk and a decline in the issuer's financial autonomy.
Analisis pesaing
Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|HRMY (Harmony Biosciences) - Total Utang marang Modal|Total Utang marang Modal biohavenpharma.com|Utang marang Ekuitas Amylyx Pharmaceuticals, Inc. (AMLX)|Koefisien Total Utang marang Modal Trevi Therapeutics Inc|Utang marang Ekuitas Praxis Medicines PRAX|Koefisien Total Utang marang Modal Anavex Life Sciences Corp (AVXL)|CeriBell, Inc. - Total Utang marang Modal|Utang marang Modal Prothena Corporation PLC|alector.com (ALEC) - Utang marang Ekuitas|Annexon Biosciences - Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas OMER|NGNE (Neurogene Therapeutics) - Utang Agregat marang Modal|Total Utang marang Modal ACIU|Koefisien Total Utang marang Modal voyagertherapeutics.com|Utang marang Ekuitas Neumora Therapeutics, Inc. NMRA|Scilex Holding (SCLX) - Utang marang Modal|TVGN: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ACOG (Alpha Cognition)|CGTX: Total Utang marang Modal|inhibikase.com - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Cassava Sciences|Utang marang Modal Coya COYA|Utang marang Ekuitas Vistagen Therapeutics (VTGN)|Utang marang Ekuitas OVID (ovidrx.com)|Total Utang marang Modal ABOS (Acumen Pharmaceuticals)|CRVO: Rasio Utang marang Ekuitas|Alterity Therapeutics Ltd - Total Utang marang Modal|Koefisien Total Utang marang Modal Clene Inc. CLNN|pepgen.com (PEPG) - Utang marang Ekuitas|Rasio Utang marang Ekuitas JUNS|RLMD (Relmada Therapeutics) - Total Utang marang Modal|ANVS - Rasio Utang marang Modal|Utang marang Ekuitas Grace Therapeutics, Inc. (GRCE)|Koefisien Total Utang marang Modal Firefly Neuroscience, Inc.|Klotho Neurosciences - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi NRSN|Reviva Pharmaceuticals - Total Utang marang Modal|Koefisien Total Utang marang Modal MetaVia Inc MTVA|NeurAxis (NRXS) - Utang marang Ekuitas|Rasio Utang marang Ekuitas HSDT|PASG (Passage Bio Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Neuphoria (NEUP)|Rasio Total Utang marang Ekuitas NERV (Minerva Neurosciences)|Koefisien Total Utang marang Modal athira.com|Total Utang marang Modal ADXN (Addex Therapeutics Ltd)|Total Utang marang Modal Alzamend Neuro Inc. ALZN|CYCN - Utang marang Ekuitas|Koefisien Total Utang marang Modal Protagenic Therapeutics PTIX|pasitheaclinics.com (KTTA) - Utang marang Ekuitas|Cortigent - Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas ATXI|BCLI (Brainstorm Cell Therapeutics Inc.) - Utang Agregat marang Modal|Utang marang Ekuitas Cara Therapeutics, Inc (CARA)|Chromocell - Rasio Utang marang Ekuitas|Total Utang marang Modal ELYM (Eliem Therapeutics Inc.)|Intra-Cellular Therapies Inc. (ITCI) - Utang marang Modal|LBPH: Rasio Total Utang marang Ekuitas|MRNS - Total Utang marang Modal|NKGen (NKGN) - Utang marang Ekuitas|NeuroBo Pharma - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Sage Therapeutics, Inc.|Utang marang Modal synaptogen.com SNPX|Total Utang marang Modal TRVN|Total Utang marang Modal vigilneuro.com (VIGL)|Utang marang Ekuitas Anew Medical WENA|Koefisien Total Utang marang Modal Cerevel Corp (CERE)